T-cells are the immune system's frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial ...
Human immunodeficiency virus-1 (HIV-1), the causative agent of AIDS, impacts millions of people. Entry into target cells is mediated by the HIV-1 envelope (Env) glycoprotein interacting with host ...
In the ongoing effort to find new therapeutics for infants born infected with the human immunodeficiency virus, an ...
A team of scientists led by the Institute of Biomaterials and Bioengineering at Tokyo Medical and Dental University (TMDU) have created novel molecules that prevent human immunodeficiency virus (HIV) ...
A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...
Hepatitis B virus (HBV) infection is associated with increased mortality for liver-related diseases in human immunodeficiency virus (HIV)-positive patients 1,2, and chronic HBV infection (CHB) is ...
A review found that CD4/CD8 ratio could be used as a prognostic marker for mortality in patients with HIV, though future studies need to be done to confirm these findings. Clinical practices can ...
Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results